Aurobindo adds ex Ranbaxy exec; Recipharm to make drug for RedHill;

> Aurobindo has named former Ranbaxy Laboratories exec Sanjeev Dani as chief operating officer and head of formulation business. Story

> Recipharm has an agreement to manufacture RedHill Biopharma's RHB-105 for the treatment of H. pylori infection. Release

> Steven Yoder, after a nearly 30 years with film coating company Colorcon, has been named to head business development for TruTag Technologies, makers of an edible tracking technology for pharmaceuticals. Release

> China's WuXi PharmaTech ($WX) says its small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical has gotten approval from Japan's PMDA to produce an intemediate of a branded commercial drug. Release

Suggested Articles

Hospital-backed Civica Rx has struck a deal for a CDMO to help it develop its own brand of drugs, for which it will own the rights.

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.